Viewing Study NCT02177032


Ignite Creation Date: 2025-12-24 @ 9:34 PM
Ignite Modification Date: 2026-01-05 @ 5:42 PM
Study NCT ID: NCT02177032
Status: COMPLETED
Last Update Posted: 2017-04-07
First Post: 2014-06-24
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Safety and Immunogenicity of Two Intradermal Rabies Vaccine Regimens Administered With and Without Human Rabies Immunoglobulin in Subjects ≥ 1 Years of Age
Sponsor: Novartis
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: V49_30
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View